EP3449924A4 - Composition, site actif de crocines, et leurs utilisations - Google Patents

Composition, site actif de crocines, et leurs utilisations Download PDF

Info

Publication number: EP3449924A4
Authority: EP; European Patent Office
Prior art keywords: crocines; composition; active site; site; active
Prior art date: 2016-04-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP17788552.2A

Other languages

German (de)

English (en)

Other versions

EP3449924A1 (fr

EP3449924B1 (fr

Inventor

Xinsheng Yao

Dan Zhang

Yang Yu

Xiuqi BAO

Yang Ni

Caixia ZANG

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Jinan University

University of Jinan

Original Assignee

Jinan University

University of Jinan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-04-29

Filing date

2017-03-16

Publication date

2019-05-15

2017-03-16 Application filed by Jinan University, University of Jinan filed Critical Jinan University

2019-03-06 Publication of EP3449924A1 publication Critical patent/EP3449924A1/fr

2019-05-15 Publication of EP3449924A4 publication Critical patent/EP3449924A4/fr

2021-02-24 Application granted granted Critical

2021-02-24 Publication of EP3449924B1 publication Critical patent/EP3449924B1/fr

Status Active legal-status Critical Current

2037-03-16 Anticipated expiration legal-status Critical

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Botany (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Medical Informatics (AREA)
Alternative & Traditional Medicine (AREA)
Microbiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP17788552.2A 2016-04-29 2017-03-16 Composition, site actif de crocines, et leurs utilisations Active EP3449924B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CN201610284549.7A CN105935363B (zh)	2016-04-29	2016-04-29	组合物、藏红花色素类活性部位及其用途
PCT/CN2017/076910 WO2017185899A1 (fr)	2016-04-29	2017-03-16	Composition, site actif de crocines, et leurs utilisations

Publications (3)

Publication Number	Publication Date
EP3449924A1 EP3449924A1 (fr)	2019-03-06
EP3449924A4 true EP3449924A4 (fr)	2019-05-15
EP3449924B1 EP3449924B1 (fr)	2021-02-24

Family

ID=57152137

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP17788552.2A Active EP3449924B1 (fr)	2016-04-29	2017-03-16	Composition, site actif de crocines, et leurs utilisations

Country Status (6)

Country	Link
US (1)	US10851129B2 (fr)
EP (1)	EP3449924B1 (fr)
JP (1)	JP6782790B2 (fr)
CN (1)	CN105935363B (fr)
AU (1)	AU2017255362B2 (fr)
WO (1)	WO2017185899A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN105935363B (zh)	2016-04-29	2017-03-08	暨南大学	组合物、藏红花色素类活性部位及其用途
CN107648346A (zh) *	2017-10-26	2018-02-02	暨南大学	藏红花色素类组合物在制备治疗或改善抑郁症的药物中的应用
JP7355394B2 (ja) *	2018-05-03	2023-10-03	エル．イー．エー．エフ．ホールディングスグループエルエルシー	カロテノイド組成物およびその使用
CN109045047B (zh) *	2018-08-06	2020-04-28	暨南大学	藏红花色素类组合物在制备用于治疗帕金森症的药物中的应用
US20230210803A1 (en) *	2020-04-09	2023-07-06	L.E.A.F. Holdings Group Llc	Trans-crocetin compositions and treatment regimens
US12622874B2 (en)	2020-04-09	2026-05-12	L.E.A.F. Holdings Group Llc	Trans-crocetin compositions and treatment regimens
CN112552169B (zh) *	2020-12-08	2023-03-14	江西省科学院应用化学研究所	藏红花酸二酯类化合物及其制备方法和应用
CN113913029B (zh) *	2021-11-13	2023-11-24	福建师范大学	一种制备黄栀子有效成分的方法
CN117551152A (zh) *	2023-11-13	2024-02-13	河北医科大学	一种新型西红花苷化合物及其提取方法和在治疗糖尿病中的用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100210572A1 (en) *	2009-02-18	2010-08-19	Thomas Eidenberger	Hydrolysate of crocin
CN105906672A (zh) *	2016-04-29	2016-08-31	暨南大学	藏红花色素类化合物及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1347868A (zh)	2000-10-08	2002-05-08	程锦雁	藏红花的提取物具有改善脑机能的功能
CN100478348C (zh) *	2007-02-02	2009-04-15	华东理工大学	栀子果实中环烯醚萜苷和藏红花素的分离富集方法
CN102516325B (zh)	2011-11-15	2014-04-09	江西中天农业生物工程有限公司	一种以栀子为原料生产纯度大于95%的藏红花素的方法
CN102432455B (zh) *	2011-12-14	2014-02-19	广西大学	一种制备藏花酸和藏花素的方法
CN102898864B (zh) *	2012-11-09	2013-12-18	苏州衷中医药科技有限公司	一种采用溶剂结晶精制栀子黄色素的方法
US9211298B2 (en) *	2012-11-16	2015-12-15	Song Gao	Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
CN103387489B (zh) *	2013-07-11	2015-05-06	苏州大学	一种高纯度藏红花素和栀子苷的制备方法
CN105935363B (zh)	2016-04-29	2017-03-08	暨南大学	组合物、藏红花色素类活性部位及其用途

2016
- 2016-04-29 CN CN201610284549.7A patent/CN105935363B/zh active Active
2017
- 2017-03-16 US US16/097,247 patent/US10851129B2/en active Active
- 2017-03-16 JP JP2018556347A patent/JP6782790B2/ja active Active
- 2017-03-16 AU AU2017255362A patent/AU2017255362B2/en active Active
- 2017-03-16 WO PCT/CN2017/076910 patent/WO2017185899A1/fr not_active Ceased
- 2017-03-16 EP EP17788552.2A patent/EP3449924B1/fr active Active

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100210572A1 (en) *	2009-02-18	2010-08-19	Thomas Eidenberger	Hydrolysate of crocin
CN105906672A (zh) *	2016-04-29	2016-08-31	暨南大学	藏红花色素类化合物及其用途
EP3450444A1 (fr) *	2016-04-29	2019-03-06	Jinan University	Composés de type crocine et utilisations correspondantes

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
YANG NI ET AL: "Discovery and LC-MS Characterization of New Crocins in Gardeniae Fructus and Their Neuroprotective Potential", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 65, no. 14, 9 December 2016 (2016-12-09), US, pages 2936 - 2946, XP055568434, ISSN: 0021-8561, DOI: 10.1021/acs.jafc.6b03866 *
YU ET AL: "Studies on Chemical Constituents of Gardenia Jasminoides for the Treatment of Alzheimer's Diseases", 1 January 2010 (2010-01-01), pages 1 - 2012, XP009510794, Retrieved from the Internet <URL:http://big5.oversea.cnki.net/KCMS/detail/detailall.aspx?filename=2010198322.nh&dbcode=CDFD&dbname=CDFDTEMP> *

Also Published As

Publication number	Publication date
JP2019514915A (ja)	2019-06-06
EP3449924A1 (fr)	2019-03-06
US10851129B2 (en)	2020-12-01
AU2017255362B2 (en)	2020-05-21
JP6782790B2 (ja)	2020-11-11
US20190112326A1 (en)	2019-04-18
EP3449924B1 (fr)	2021-02-24
AU2017255362A1 (en)	2018-11-15
WO2017185899A1 (fr)	2017-11-02
CN105935363B (zh)	2017-03-08
CN105935363A (zh)	2016-09-14

Legal Events

Date	Code	Title	Description
2017-11-04	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2019-02-01	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2019-02-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2019-03-06	17P	Request for examination filed	Effective date: 20181026
2019-03-06	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2019-03-06	AX	Request for extension of the european patent	Extension state: BA ME
2019-05-10	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2019-05-15	A4	Supplementary search report drawn up and despatched	Effective date: 20190417
2019-05-15	RIC1	Information provided on ipc code assigned before grant	Ipc: A23L 33/105 20160101ALI20190411BHEP Ipc: A61K 31/7024 20060101AFI20190411BHEP Ipc: A61P 25/28 20060101ALI20190411BHEP Ipc: C07H 13/04 20060101ALI20190411BHEP Ipc: A61K 36/88 20060101ALI20190411BHEP
2019-06-12	17Q	First examination report despatched	Effective date: 20190514
2019-08-07	DAV	Request for validation of the european patent (deleted)
2019-08-07	DAX	Request for extension of the european patent (deleted)
2020-09-18	REG	Reference to a national code	Ref country code: DE Ref legal event code: R079 Ref document number: 602017033380 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61K0031702400 Ipc: C07H0013040000
2020-10-28	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 25/28 20060101ALI20200918BHEP Ipc: A61K 36/744 20060101ALI20200918BHEP Ipc: C07H 13/04 20060101AFI20200918BHEP Ipc: C07H 13/06 20060101ALI20200918BHEP Ipc: A61K 31/7024 20060101ALI20200918BHEP Ipc: A23L 33/105 20160101ALI20200918BHEP
2020-11-02	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2020-11-02	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: GRANT OF PATENT IS INTENDED
2020-12-02	INTG	Intention to grant announced	Effective date: 20201103
2021-01-15	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2021-01-22	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2021-01-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE PATENT HAS BEEN GRANTED
2021-02-24	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2021-02-26	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2021-03-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: REF Ref document number: 1364313 Country of ref document: AT Kind code of ref document: T Effective date: 20210315
2021-03-17	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2021-03-18	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602017033380 Country of ref document: DE
2021-07-12	REG	Reference to a national code	Ref country code: LT Ref legal event code: MG9D
2021-07-28	REG	Reference to a national code	Ref country code: NL Ref legal event code: MP Effective date: 20210224
2021-07-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210624 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210524 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210525 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210524 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224
2021-08-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: MK05 Ref document number: 1364313 Country of ref document: AT Kind code of ref document: T Effective date: 20210224
2021-08-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224
2021-09-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210624
2021-10-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224
2021-10-29	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2021-11-25	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602017033380 Country of ref document: DE
2021-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224
2021-12-16	REG	Reference to a national code	Ref country code: BE Ref legal event code: MM Effective date: 20210331
2021-12-31	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2021-12-31	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2022-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210316 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210331 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210331 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210316
2022-02-02	26N	No opposition filed	Effective date: 20211125
2022-02-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224
2022-04-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224
2022-06-01	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210624
2022-07-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210331
2023-06-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224
2023-07-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20170316
2024-04-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224
2024-06-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224
2024-09-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210224
2026-04-09	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: GB Payment date: 20260309 Year of fee payment: 10
2026-04-13	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DE Payment date: 20260320 Year of fee payment: 10
2026-04-20	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: FR Payment date: 20260309 Year of fee payment: 10

Publication	Publication Date	Title
FR24C1023I2 (fr)	2026-04-03	Anticorps thérapeutiques et leurs utilisations
MA46990A (fr)	2019-05-01	Compositions de glp-1 et leurs utilisations
EP3600273A4 (fr)	2021-01-20	Inhibiteurs de cd73 et leurs utilisations
EP3419676A4 (fr)	2020-03-18	Compositions antimicrobiennes et leurs utilisations
EP3328199A4 (fr)	2019-02-27	Compositions antimicrobiennes et leurs utilisations
MA50618A (fr)	2020-08-12	Polyrhérapies et leurs utilisations
EP3377102C0 (fr)	2023-08-09	Anticorps anti-pd-1 et leurs utilisations thérapeutiques
MA49537A (fr)	2020-05-13	Anticorps anti-lag3 et leurs utilisations
EP3344624A4 (fr)	2019-01-16	Inhibiteurs de tyk2 et leurs utilisations
EP3337470A4 (fr)	2019-02-27	Conjugués d'aldéhyde et leurs utilisations
EP3337486A4 (fr)	2019-03-06	Composés deutérés et leurs utilisations
EP3340988A4 (fr)	2019-05-15	Composés inhibiteurs de canaux ioniques, formulations pharmaceutiques, et utilisations
EP3463277A4 (fr)	2020-01-01	Formulations de 3-pyrrolidines substituées, compositions contenant celles-ci et leurs utilisations
EP3283516A4 (fr)	2019-03-06	Anticorps anti-pacap et leurs utilisations
EP3370528A4 (fr)	2019-05-01	Compositions probiotiques et leurs utilisations
MA43821A (fr)	2018-11-28	Pyrimidines et variantes de celles-ci, et leurs utilisations
EP3426244A4 (fr)	2019-11-06	Inhibiteurs de la 3-phosphoglycérate déshydrogénase et leurs utilisations
EP3341007A4 (fr)	2019-05-01	Inhibiteurs de malt1 et leurs utilisations
EP3655043A4 (fr)	2021-04-28	Compositions topiques et leurs utilisations
EP3426243A4 (fr)	2019-07-03	Inhibiteurs de la 3-phosphoglycérate déshydrogénase et leurs utilisations
EP3347021A4 (fr)	2019-07-24	Cyano-thiénotriazoloazépines et leurs utilisations
EP3399978A4 (fr)	2019-08-07	Composés antiprolifératifs, leurs compositions pharmaceutiques et leurs utilisations
EP3432859A4 (fr)	2019-12-04	Compositions cosmétiques et leurs utilisations
MA44489A (fr)	2019-01-30	Pyrimidines et variants de celles-ci, et leurs utilisations
MA46901A (fr)	2019-10-02	Agents psychotropes et leurs utilisations